Post Marketing Surveillance(PMS) Study of Lorviqua in Korea
Post Marketing Surveillance(PMS) Study of Lorviqua in Korea
Recruiting · NCT05599412 · Registry updated 2026-03-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Post Marketing Surveillance(PMS) Study of Lorviqua in Korea | Metastatic ALK+ Non Small Cell Lung Cancer | Recruiting | Not stated | 2026-03-27 | NCT05599412 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pfizer | 431 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Pfizer | Seoul | South Korea | 8 |